J. Michael Dixon

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Chad J. Creighton, Xiaoxian Li, Melissa D. Landis et al. · Proceedings of the National Academy of Sciences · 2009 · 1.4K citations · Full text

Medicine, Cancer Biology, Oncology +16

Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets

Luca Cassetta, Stamatina Fragkogianni, Andrew H. Sims et al. · Cancer Cell · 2019 · 953 citations · Full text

Medicine, Cancer Biology, Oncology +17

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial

Ian Kunkler, Linda Williams, W Jack et al. · The Lancet Oncology · 2015 · 902 citations

Medicine, Oncology, Surgery +13

Prognostic Value of Ki67 Expression After Short-Term Presurgical Endocrine Therapy for Primary Breast Cancer

Mitch Dowsett, Ian E. Smith, S. Ebbs et al. · JNCI Journal of the National Cancer Institute · 2007 · 666 citations · Full text

Medicine, Oncology, Pharmacology +17

Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes

Colm E. Nestor, Raffaele Ottaviano, James P. Reddington et al. · Genome Research · 2011 · 409 citations · Full text

Life Sciences, Biology, Genetics +15